IL196773A0 - Stable solid elsamitrucin salts suitable for pharmaceutical formulations - Google Patents

Stable solid elsamitrucin salts suitable for pharmaceutical formulations

Info

Publication number
IL196773A0
IL196773A0 IL196773A IL19677309A IL196773A0 IL 196773 A0 IL196773 A0 IL 196773A0 IL 196773 A IL196773 A IL 196773A IL 19677309 A IL19677309 A IL 19677309A IL 196773 A0 IL196773 A0 IL 196773A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulations
stable solid
salts suitable
elsamitrucin salts
solid elsamitrucin
Prior art date
Application number
IL196773A
Original Assignee
Spectrum Pharmaceuticals Inc
Luigi Lenaz
Guru Reddy
Ashok Gore
Fred Defesche
Grant J Palmer
Jonathon S Salsbury
Hemant Joshi
Olga V Lapina
Paul K Isbester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc, Luigi Lenaz, Guru Reddy, Ashok Gore, Fred Defesche, Grant J Palmer, Jonathon S Salsbury, Hemant Joshi, Olga V Lapina, Paul K Isbester filed Critical Spectrum Pharmaceuticals Inc
Publication of IL196773A0 publication Critical patent/IL196773A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL196773A 2007-05-24 2009-01-28 Stable solid elsamitrucin salts suitable for pharmaceutical formulations IL196773A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/069693 WO2008143677A1 (en) 2007-05-24 2007-05-24 Stable solid elsamitrucin salts suitable for pharmaceutical formulations

Publications (1)

Publication Number Publication Date
IL196773A0 true IL196773A0 (en) 2009-11-18

Family

ID=39639324

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196773A IL196773A0 (en) 2007-05-24 2009-01-28 Stable solid elsamitrucin salts suitable for pharmaceutical formulations

Country Status (6)

Country Link
KR (1) KR20100014080A (en)
CN (1) CN101472938A (en)
CA (1) CA2654877A1 (en)
IL (1) IL196773A0 (en)
MX (1) MX2008015971A (en)
WO (1) WO2008143677A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222276A1 (en) * 2007-12-19 2010-09-01 Spectrum Pharmaceuticals, Inc. Stable elsamitrucin salt formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
HU210499B (en) * 1991-05-30 1995-04-28 Bristol Myers Squibb Co Process for preparing 6-o-alkylelsamicin a deriv.s and pharmaceutical compn.s contg. them
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations

Also Published As

Publication number Publication date
KR20100014080A (en) 2010-02-10
WO2008143677A1 (en) 2008-11-27
MX2008015971A (en) 2009-01-12
CA2654877A1 (en) 2008-11-27
CN101472938A (en) 2009-07-01

Similar Documents

Publication Publication Date Title
HK1217440A1 (en) Acid containing lipid formulations
ZA200908019B (en) Controlled release pharmaceutical compositions for prolonged effect
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
GB0721095D0 (en) Pharmaceutical compounds
GB0711656D0 (en) Formulations
EP2178893A4 (en) Oral formulations for picoplatin
EP2001500A4 (en) Formulations for ecallantide
GB0707087D0 (en) Pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
GB0711957D0 (en) Formulations
GB0704932D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
GB0710899D0 (en) Formulations
ZA201007197B (en) Raloxifene pharmaceutical formulations
IL198160A0 (en) Pharmaceutical formulations
IL196773A0 (en) Stable solid elsamitrucin salts suitable for pharmaceutical formulations
GB0705179D0 (en) Formulations
ZA200901424B (en) Stable solid elsamitrucin salts suitable for pharmaceutical formulations
GB0713093D0 (en) Pharmaceutical formulations
IL206473A0 (en) Stable elsamitrucin salt formulations
GB0810217D0 (en) Pharmaceutical formulations
GB0813031D0 (en) Pharmaceutical formulations
GB0615461D0 (en) Pharmaceutical formulations
GB0709150D0 (en) Pharmaceutical compounds